Biotech Values

[masterlongevity]

" but the decline in ADAS scores for treatment patients are grossly in line with Aricept studies if memory serves."

I would argue that the change in ADAS score are meaningless (for this type of medication (of course, am sure FDA disagrees)). the real goal is to change the course of the disease and then to treat earlier so that patients have a chacne not to become this demented.